Following a thorough analysis and retrieval, it has been determined that NEK7 and LHX9 within Activated & resting Treg %CD4 + cell, along with DN (CD4-CD8-) %leukocyte, hold promising potential as therapeutic targets for drug treatment of colorectal cancer. This evidence concerns the gene LHX9 and colorectal cancer.